A pair of bacteria that should not be confused
Most people have never heard of nontuberculous mycobacteria, or NTM. The name tells you what they are not: not the bug that causes tuberculosis. But it does not tell you what they are.
NTMs are a diverse group of bacteria that live in soil, water, and dust. Most are harmless. A small number can cause chronic lung infections, especially in people with existing lung problems or weakened immune systems.
Two of the lesser-known members of this group, Mycobacterium septicum and Mycolicibacterium nivoides, look almost identical in a lab. That has made them hard to tell apart. It has also made it hard to know what they really do inside patients.
NTM lung infections are rising. Modern medicine has extended the lives of people with conditions like COPD, bronchiectasis, and cystic fibrosis. Those patients are more vulnerable to NTM.
Getting the right diagnosis matters. Different NTM species respond to different antibiotic combinations. Missing the identity of the bug can mean months of wrong treatment.
Old way vs. new approach
Traditional lab methods often identified only one bacterium per culture. If two similar species were growing together, one usually got overlooked. And if a single colony was picked for analysis, other strains in the same sample went untested.
This new study used genome sequencing on multiple colonies from the same sample. That wider lens revealed surprises.
How it works, in plain English
Think of diagnosing a bacterial infection like taking a photo of a crowd. The old way was taking one face in focus and assuming everyone in the shot was the same person. The new way is high-resolution imaging, so each face becomes clearly its own.
By reading the full DNA of 20 colonies from each sample, scientists can spot when multiple species or strains are present. They can also see how each one has evolved during the infection.
The study snapshot
Researchers focused on a single patient with a chronic pulmonary infection. They grew the bacteria from respiratory samples, picked 20 colonies from each sample, and sequenced every one.
They also reviewed past published cases and pulled publicly available genomes to see how often these two species had been missed or misidentified elsewhere.
Here's what they found
Both M. septicum and M. nivoides were present in the same lung infection. That was the first documented case of co-infection with these two species.
More strikingly, each bacterium had evolved within the patient. M. septicum picked up changes in one gene related to fat breakdown. M. nivoides picked up a change in a different gene that affects its cell wall.
Both changes made the bacteria more virulent in a model organism used for testing, the waxworm caterpillar.
When researchers reviewed other cases, they found 19 additional M. septicum reports. They also found that some publicly available genomes previously labeled as related species were actually misclassified M. nivoides.
This is where things get interesting.
The bacteria may be smarter than we thought. Within the same patient, they independently adapted toward stronger infection capability. That convergence, landing at similar ends through different genetic routes, suggests real evolutionary pressure inside the lungs.
How the researchers read it
The authors argue for picking multiple colonies during standard lab diagnosis. One colony is not enough to spot genetic variation or co-infection.
They also caution about lab classification. If M. nivoides has been routinely mislabeled, real estimates of how often it causes infection are probably underestimates.
If you or a family member have a chronic lung infection, especially one that has not responded well to antibiotics, ask your specialist whether full NTM identification was done. Ask whether the lab checked for multiple species.
If you live with conditions like bronchiectasis or cystic fibrosis, stay on top of lung care. Regular monitoring, airway clearance techniques, and early treatment of infections make a real difference.
For most healthy people, NTM is not something to worry about. These bacteria rarely cause infections in those with normal immune systems and lung function.
The limits
This was a detailed study of one patient. One case cannot tell us how common this kind of co-infection really is, or whether the evolutionary changes matter for human outcomes.
The virulence testing used an insect model. How the bacteria behave in humans may differ.
The literature review was also constrained by what researchers chose to publish. Unreported cases remain invisible.
The authors call for broader sequencing of NTM samples. Multi-colony picking, already standard in some research labs, should move toward routine clinical practice.
They also suggest that NTM databases need clean-up. If mislabeled entries are skewing analyses, real patterns could be hidden in plain sight.
